Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Riociguat for Sarcoidosis-Associated Pulmonary Hypertension

CHEST Journal(2021)10.1016/j.chest.2021.07.2162Source: DataRank Database

Riociguat for Sarcoidosis-Associated Pulmonary Hypertension is a research paper published in CHEST Journal (2021). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.77)OA: greenTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (4)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Oksana A. Shlobin ORCID,Rohit Gupta ORCID,Peter J. Engel ORCID,Jeffrey Stewart,Elyse E. Lower ORCID

Live enrichment

PubMed:34363816 PMC:PMC9005858 OpenAlex:https://openalex.org/W3187270436

National Institutes of Health

Grant: 2UL1TR001425-05A1

Center for Clinical and Translational Science and Training

NCATS NIH HHS

Grant: UL1 TR001425

United Therapeutics Corporation

Bayer Corp

Bayer Fund

Pharmaceuticals Bayer

FWCI

3.77

Citation Percentile

0.9%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9005858

BRONZEhttps://www.sciencedirect.com/science/article/am/pii/S0012369221036138

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9005858

publisherhttps://api.elsevier.com/content/article/PII:S0012369221036138?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0012369221036138?httpAccept=text/plain

Fields of Study

Sarcoidosis and Beryllium Toxicity ResearchPulmonary Hypertension Research and TreatmentsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine03 medical and health sciences0302 clinical medicine

MeSH Terms

Walk TestAgedDouble-Blind MethodFemaleHumansHypertension, PulmonaryMaleMiddle AgedPyrazolesPyrimidinesQuality of LifeSarcoidosisSpirometryDisease ProgressionEnzyme Activators

Keywords

RiociguatPlaceboMedicinePulmonary hypertensionChronic thromboembolic pulmonary hypertensionInternal medicineCardiologyPulmonary fibrosis6-Min Walk DistanceSarcoidosis-associated Pulmonary Hypertension

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being